Literature DB >> 16788980

Indole, a core nucleus for potent inhibitors of tubulin polymerization.

Andrea Brancale1, Romano Silvestri.   

Abstract

Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti-cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi-synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti-tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure - activity relationship aspects of 3-formyl-2-phenylindoles, heterocombretastatins, diarylindoles, 2-aroylindoles, D-24851, 2-aryl-3-aroylindoles, 3-aroyl- and 1-aroylindoles, and arylthioindoles are discussed. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16788980     DOI: 10.1002/med.20080

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  24 in total

1.  Accessible haptic technology for drug design applications.

Authors:  Nicola Zonta; Ian J Grimstead; Nick J Avis; Andrea Brancale
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

2.  Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents.

Authors:  Gökçe Cihan-Üstündağ; Gültaze Capan
Journal:  Mol Divers       Date:  2012-08-15       Impact factor: 2.943

3.  Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents.

Authors:  Dong-Jin Hwang; Jin Wang; Wei Li; Duane D Miller
Journal:  ACS Med Chem Lett       Date:  2015-08-06       Impact factor: 4.345

4.  Fe(II)-catalyzed amination of aromatic C-H bonds via ring opening of 2H-azirines: synthesis of 2,3-disubstituted indoles.

Authors:  Samaresh Jana; Mack D Clements; Barry K Sharp; Nan Zheng
Journal:  Org Lett       Date:  2010-09-03       Impact factor: 6.005

5.  Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway.

Authors:  Gowdahalli Krishnegowda; A S Prakasha Gowda; Hephzibah Rani S Tagaram; Kevin F Staveley-O' Carroll; Rosalyn B Irby; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2011-08-26       Impact factor: 3.641

6.  Synthesis of 3-sulfenyl- and 3-selenylindoles by the Pd/Cu-catalyzed coupling of N,N-dialkyl-2-iodoanilines and terminal alkynes, followed by n-Bu(4)NI-induced electrophilic cyclization.

Authors:  Yu Chen; Chul-Hee Cho; Feng Shi; Richard C Larock
Journal:  J Org Chem       Date:  2009-09-04       Impact factor: 4.354

7.  An Efficient, Microwave-Assisted, One-Pot Synthesis of Indoles Under Sonogashira Conditions.

Authors:  Yu Chen; Nataliya A Markina; Richard C Larock
Journal:  Tetrahedron       Date:  2009-10-31       Impact factor: 2.457

8.  A novel synthetic route to 3-sulfenyl- and 3-selenylindoles by n-Bu4NI-induced electrophilic cyclization.

Authors:  Yu Chen; Chul-Hee Cho; Richard C Larock
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

9.  Arylthioindoles: Promising compounds against cancer cell proliferation.

Authors:  Vincenzo Giansanti; Francesco Piscitelli; Tania Camboni; Ennio Prosperi; Giuseppe LA Regina; Michele Parks; Romano Silvestri; Anna Ivana Scovassi
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Olga Cruz-Lopez; Carlota Lopez Cara; Delia Preti; Mojgan Aghazadeh Tabrizi; Jan Balzarini; Ernest Hamel; Enrica Fabbri; Roberto Gambari
Journal:  Lett Drug Des Discov       Date:  2009-06-01       Impact factor: 1.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.